Showing results (751-760 of 5,666) with videos related to

Sort By:
Pageof 567
Drug Design, Development and Therapy|February 7, 2018
Bispecific antibodies: design, therapy, perspectivesSergey E Sedykh, Victor V Prinz, Valentina N Buneva, et al.
Drug Design, Development and Therapy|November 11, 2017
10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexesJianxin Zhang, Chen Ming, Wenzhi Zhang, et al.
Drug Design, Development and Therapy|November 11, 2017
High-dose dexamethasone induced LPS-stimulated rat alveolar macrophages apoptosisSi Zeng, Hui Qiao, Xue-Wen Lv, et al.
Drug Design, Development and Therapy|January 2, 2018
Resveratrol as a potential therapeutic drug for respiratory system diseasesXiao-Dan Zhu, Xiao-Ping Lei, Wen-Bin Dong
Drug Design, Development and Therapy|January 3, 2018
Erratum: Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]
Drug Design, Development and Therapy|February 9, 2018
The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trialsTzu-Lin Yeh, Pei-Ching Shih, Shu-Jung Liu, et al.
Drug Design, Development and Therapy|December 26, 2018
The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblastsHana Polachek, Nir Debotton, Valeria Feinshtein, et al.
Drug Design, Development and Therapy|December 26, 2018
SREBP-2, a new target of metformin?Fengxia Zhang, Wenxiu Sun, Jianbo Chen, et al.
Drug Design, Development and Therapy|December 26, 2018
Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weightsMohamed M Ibrahim, Abdulla M Abuelmatty, Gehan H Mohamed, et al.
Drug Design, Development and Therapy|December 28, 2018
MMI-0100 ameliorates lung inflammation in a mouse model of acute respiratory distress syndrome by reducing endothelial expression of ICAM-1Binchan He, Shen Geng, Wei Zhou, et al.
Pageof 567